Lukas H Margaritis Selected Research

Oncogene Protein pp60(v-src) (pp60 v-src)

1/2007

Drug-mediated targeted disruption of multiple protein activities through functional inhibition of the Hsp90 chaperone complex.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lukas H Margaritis Research Topics

Disease

7	Neoplasms (Cancer) 01/2020 - 01/2007
5	Urinary Bladder Neoplasms (Bladder Cancer) 02/2011 - 12/2008
2	Memory Disorders (Memory Loss) 01/2018 - 12/2012
2	Diabetic Retinopathy (Retinopathy, Diabetic) 08/2009 - 08/2007
2	alpha-Thalassemia 01/2003 - 01/2003
1	Neuroblastoma 09/2019
1	Genomic Instability 04/2017
1	Prostatic Neoplasms (Prostate Cancer) 04/2017
1	Brain Neoplasms (Brain Tumor) 12/2012
1	Headache (Headaches) 12/2012
1	Fatigue 12/2012
1	Parkinson Disease (Parkinson's Disease) 05/2010
1	Atherosclerosis 05/2009
1	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2009
1	Odontogenic Tumors (Dental Tissue Neoplasm) 01/2009
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2009
1	Stomatognathic Diseases (Dental Disease) 01/2009
1	Carcinogenesis 01/2009
1	Diabetes Complications 08/2007
1	Drug-Related Side Effects and Adverse Reactions 01/2007
1	Colonic Neoplasms (Colon Cancer) 01/2007
1	Thalassemia 01/2003
1	Protein Deficiency 01/2003
1	Diabetic Nephropathies (Diabetic Nephropathy) 08/2002

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 09/2019 - 01/2003
3	Pharmaceutical PreparationsIBA 02/2011 - 01/2007
2	alpha-SynucleinIBA 09/2019 - 05/2010
2	Small Interfering RNA (siRNA)IBA 03/2012 - 01/2009
2	tanespimycin (17AAG)IBA 09/2010 - 01/2007
2	ClusterinIBA 05/2009 - 01/2009
1	peptide-Gly-Leu-amideIBA 01/2020
1	AntioxidantsIBA 01/2020
1	PhloroglucinolIBA 01/2020
1	Parasympatholytics (Antispasmodics)IBA 01/2020
1	Peroxidase (Myeloperoxidase)IBA 01/2020
1	Amyloid (Amyloid Fibrils)IBA 09/2019
1	ProteomeIBA 01/2018
1	Biological ProductsIBA 04/2017
1	Fluorouracil (Carac)FDA LinkGeneric 02/2011
1	CaspasesIBA 02/2011
1	AntimetabolitesIBA 02/2011
1	Thymidylate SynthaseIBA 02/2011
1	CalciumIBA 05/2010
1	Caspase 10IBA 08/2009
1	multidrug resistance-associated protein 1IBA 08/2009
1	Cisplatin (Platino)FDA LinkGeneric 08/2009
1	Glycoproteins (Glycoprotein)IBA 05/2009
1	PoisonsIBA 01/2009
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 01/2009
1	Biomarkers (Surrogate Marker)IBA 01/2009
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2009
1	SurvivinIBA 01/2009
1	CyclinsIBA 01/2009
1	LuciferasesIBA 12/2008
1	quinone (benzoquinone)IBA 01/2007
1	purineIBA 01/2007
1	pyrazoleIBA 01/2007
1	17- (dimethylaminoethylamino)- 17- demethoxygeldanamycinIBA 01/2007
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2007
1	Oncogene Protein pp60(v-src) (pp60 v-src)IBA 01/2007
1	Rifabutin (Ansamycin)FDA Link 01/2007
1	geldanamycinIBA 01/2007
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 01/2003
1	EuchromatinIBA 01/2003
1	Hemoglobin HIBA 01/2003
1	GlobinsIBA 01/2003
1	alpha-GlobinsIBA 01/2003
1	beta-Globins (beta Globin)IBA 01/2003
1	Peptides (Polypeptides)IBA 01/2003
1	Immunoglobulins (Immunoglobulin)IBA 01/2003
1	IntegrinsIBA 08/2002
1	Matrix Metalloproteinases (MMPs)IBA 08/2002
1	Glucose (Dextrose)FDA LinkGeneric 08/2002

Therapy/Procedure

3	Therapeutics 01/2009 - 01/2007
1	Combination Drug Therapy (Combination Chemotherapy) 02/2011
1	Oral Pathology 01/2009